Loading
Breast surgeon whose margin and axillary guidelines cut unnecessary re-excisions and lymph node surgery worldwide.
Monica Morrow co-chaired the SSO-ASTRO consensus that defined 'no ink on tumour' as an adequate margin for breast conservation, sharply reducing re-excision rates, and has led the evidence for omitting axillary dissection after positive sentinel nodes. She chairs the breast service at MSKCC and has been president of the Society of Surgical Oncology. Her work continues on tailoring surgery to response after neoadjuvant therapy.
Shares Sentinel lymph node biopsy, HR-positive / HER2-negative breast cancer and the tags breast, surgery, de-escalation.
Shares Society of Surgical Oncology, HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
Shares Society of Surgical Oncology, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags breast, de-escalation.
Shares Memorial Sloan Kettering Cancer Center, HER2-positive breast cancer, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer and the tag breast.
Shares the tags breast, surgery, de-escalation.
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer and the tags breast, surgery.
Shares Sentinel lymph node biopsy and the tags surgery, de-escalation.